mesenchymal stem cell therapy (MCTT)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namemesenchymal stem cell therapy (MCTT)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes MellitusTrauma, Nervous SystemLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiosolution Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiosolution Co Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusTrauma, Nervous SystemLiver Cirrhosis

Other Information

ATC CodeN/A
Related LinksN/A